NUVB
Price
$3.20
Change
+$0.19 (+6.31%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.03B
40 days until earnings call
OCUL
Price
$12.53
Change
+$0.28 (+2.29%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
2.13B
45 days until earnings call
Interact to see
Advertisement

NUVB vs OCUL

Header iconNUVB vs OCUL Comparison
Open Charts NUVB vs OCULBanner chart's image
Nuvation Bio
Price$3.20
Change+$0.19 (+6.31%)
Volume$24.77K
Capitalization1.03B
Ocular Therapeutix
Price$12.53
Change+$0.28 (+2.29%)
Volume$34.56K
Capitalization2.13B
NUVB vs OCUL Comparison Chart in %
Loading...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUVB vs. OCUL commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVB is a Buy and OCUL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (NUVB: $3.20 vs. OCUL: $12.52)
Brand notoriety: NUVB and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVB: 42% vs. OCUL: 39%
Market capitalization -- NUVB: $1.03B vs. OCUL: $2.13B
NUVB [@Biotechnology] is valued at $1.03B. OCUL’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVB’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • NUVB’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVB is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVB’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 3 bullish TA indicator(s).

  • NUVB’s TA Score: 5 bullish, 4 bearish.
  • OCUL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NUVB is a better buy in the short-term than OCUL.

Price Growth

NUVB (@Biotechnology) experienced а -0.62% price change this week, while OCUL (@Biotechnology) price change was +3.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

NUVB is expected to report earnings on Nov 05, 2025.

OCUL is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2.13B) has a higher market cap than NUVB($1.03B). OCUL YTD gains are higher at: 46.663 vs. NUVB (20.301). OCUL (-200.5M) and NUVB (-201.17M) have comparable annual earnings (EBITDA) . NUVB has more cash in the bank: 608M vs. OCUL (391M). NUVB has less debt than OCUL: NUVB (57.8M) vs OCUL (76.9M). OCUL has higher revenues than NUVB: OCUL (56.7M) vs NUVB (14.4M).
NUVBOCULNUVB / OCUL
Capitalization1.03B2.13B48%
EBITDA-201.17M-200.5M100%
Gain YTD20.30146.66344%
P/E RatioN/AN/A-
Revenue14.4M56.7M25%
Total Cash608M391M155%
Total Debt57.8M76.9M75%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUVBOCUL
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USAAX44.01N/A
N/A
Victory Growth
SEGIX41.92N/A
N/A
NAA Large Cap Value C
VRMGX64.07N/A
N/A
Virtus KAR Mid-Cap Growth R6
RGLGX27.50N/A
N/A
American Funds Global Insight R-6
MMMSX22.61N/A
N/A
Victory Integrity Small/Mid-Cap Value Mb

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+6.31%
BEAM - NUVB
48%
Loosely correlated
-0.48%
DNLI - NUVB
47%
Loosely correlated
+3.87%
RCUS - NUVB
46%
Loosely correlated
+3.88%
XNCR - NUVB
45%
Loosely correlated
+12.00%
OCUL - NUVB
44%
Loosely correlated
+2.33%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+2.33%
EYPT - OCUL
65%
Loosely correlated
+5.31%
IDYA - OCUL
56%
Loosely correlated
+4.52%
NRIX - OCUL
56%
Loosely correlated
+7.20%
IMVT - OCUL
55%
Loosely correlated
+3.51%
CRNX - OCUL
55%
Loosely correlated
+27.92%
More